Transhuman Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
23
- Portfolio
-
15
- Exits
-
6
Transhuman Capital General Information
Company Description
Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan. The firm seeks to invest in the therapeutics, biotechnology, medical devices, and healthcare technologies sectors.
Business Details
Website
transhumancapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Ann Arbor, MI
- United States
Transhuman Capital Investments (23)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cyana Therapeutics | 01-Jul-2026 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Ambros Therapeutics | 16-Dec-2025 | Biotechnology | Clinical Trials - Phase 3 | |||
| Response Pharmaceuticals | 28-Jun-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Retension Pharmaceutical | 15-May-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Matter Bioworks | 19-Apr-2024 | Biotechnology | Clinical Trials - Phase 1 | |||
| Nava Therapeutics | 24-Jan-2024 | Drug Discovery | Generating Revenue | |||
| Kriya Therapeutics | 26-Jul-2023 | Drug Discovery | Clinical Trials - General | |||
| Bond Biosciences | 25-Jan-2022 | Drug Discovery | Clinical Trials - General | |||
| EVOQ Therapeutics | 25-Oct-2021 | Later Stage VC | Drug Discovery | Product Development | ||
| Eight Sleep | 30-Aug-2021 | Later Stage VC | Electronics (B2C) | Generating Revenue |
Transhuman Capital Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Retension Pharmaceutical | 09-Oct-2026 | IPO | |
| Asalyxa Bio | 05-Jul-2024 | ||
| Roivant Sciences | 30-Sep-2021 | ||
| Sio Gene Therapies | 11-Jun-2015 | IPO | |
| Marinus Pharmaceuticals | 31-Jul-2014 | IPO |
Transhuman Capital Investments by Industry, Year, and Region
Transhuman Capital Co-Investors (37)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Andreessen Horowitz | 1 |
|
|
||
| GV |
|
|
|||
| QVT Family Office |
|
|
|||
| RA Capital Management |
|
|
|||
| Versant Ventures |
|
|
Transhuman Capital FAQs
-
What is Transhuman Capital?
Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan.
-
When was Transhuman Capital founded?
Transhuman Capital was founded in 2014.
-
Where is Transhuman Capital headquartered?
Transhuman Capital is headquartered in Ann Arbor, MI.
-
How many investments has Transhuman Capital made?
Transhuman Capital has made 23 investments.
-
What has Transhuman Capital invested in?
Transhuman Capital has made numerous investments in companies like Cyana Therapeutics, Ambros Therapeutics, and Response Pharmaceuticals within the Drug Discovery and Biotechnology industries.
-
What has Transhuman Capital invested in recently?
Transhuman Capital's latest investment was on 01-Jul-2026 in Cyana Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process